TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34259636

Group type: EXPERIMENTAL
Intervention: Immersive animation (n=72)
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Text condition (n=65)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Control condition (n=69)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Immersive animation vs Control
Number of subjects: 206

Group type: COMPARATOR
Intervention: Text vs Control
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Immersive animation vs Text
Number of subjects: 206
Study: 33269837

Group type: EXPERIMENTAL
Intervention: TEAS (2 Hz/100 Hz, 3‐8 mA) at acupoints Neiguan (PC6) + Hegu (LI4) for 30 min before anesthesia until the end of the operation
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: TEAS (2 Hz/100 Hz, 3‐8 mA) at acupoints PC6 + LI4 + Zusanli (ST36) for 30 min before anesthesia until the end of the operation
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: TEAS (2 Hz/100 Hz, 3‐8 mA) at acupoints PC6 + LI4 + ST36 + Sanyinjiao (SP6) for 30 min before anesthesia until the end of the operation
Number of subjects: 140

Group type: COMPARATOR
Intervention: GA control group receiving intravenous Midazolam, Sufentanil, Propofol, Rocuronium Bromide
Number of subjects: 140
Study: 36149465

Group type: EXPERIMENTAL
Intervention: Early iron supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34941936

Group type: EXPERIMENTAL
Intervention: Perspective of passengers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Perspective of pedestrians
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Perspective of observers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fifth experiment testing social desirability bias
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Overall moral preferences
Number of subjects: 0
Study: 35378077

Group type: EXPERIMENTAL
Intervention: Cabotegravir with TDF-FTC placebo
Number of subjects: 3224

Group type: COMPARATOR
Intervention: TDF-FTC with cabotegravir placebo
Number of subjects: 3224

Group type: EXPERIMENTAL
Intervention: Cabotegravir
Number of subjects: 3224

Group type: COMPARATOR
Intervention: TDF-FTC
Number of subjects: 3224
Study: 32393096

Group type: EXPERIMENTAL
Intervention: oXiris haemofilter
Number of subjects: 35
Study: 32231356

Group type: EXPERIMENTAL
Intervention: Modern contraceptive use among 15-19 year-olds (51.7% using LARC)
Number of subjects: 1022

Group type: EXPERIMENTAL
Intervention: Modern contraceptive use among 20-24 year-olds (36.5% using LARC)
Number of subjects: 1022

Group type: EXPERIMENTAL
Intervention: Unmet need for contraception among 15-19 year-olds
Number of subjects: 1022

Group type: EXPERIMENTAL
Intervention: Unmet need for contraception among 20-24 year-olds
Number of subjects: 1022

Group type: EXPERIMENTAL
Intervention: Factors associated with modern contraceptive use
Number of subjects: 1022
Study: 35745267

Group type: EXPERIMENTAL
Intervention: Protein-rich, low-glycaemic meal replacement
Number of subjects: 463

Group type: COMPARATOR
Intervention: Control group (lifestyle intervention alone)
Number of subjects: 463
Study: 33706829

Group type: EXPERIMENTAL
Intervention: Nutrition-sensitive agroecology intervention
Number of subjects: 548

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 548
Study: 33243030

Group type: EXPERIMENTAL
Intervention: Metformin treatment (2 g/day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard diabetes prenatal care (NICE guidelines)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Metformin treatment
Number of subjects: 40
Study: 33667309

Group type: EXPERIMENTAL
Intervention: Citalopram (SSRI)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study: 32063619

Group type: EXPERIMENTAL
Intervention: Letrozole 5mg tablets per night for 3-7 days
Number of subjects: 220

Group type: COMPARATOR
Intervention: Clomiphene citrate 50mg tablets per night for 3-7 days
Number of subjects: 220
Study: 36184253

Group type: EXPERIMENTAL
Intervention: Selenium supplementation (200 μg/day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (starch)
Number of subjects: 40
Study: 33789551

Group type: EXPERIMENTAL
Intervention: Breast cancer cases
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Prostate cancer cases
Number of subjects: 22

Group type: COMPARATOR
Intervention: Cancer-free controls
Number of subjects: 22
Study: 32519676

Group type: EXPERIMENTAL
Intervention: Excerpts containing misspellings
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Excerpts containing inappropriate capitalization
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Excerpts containing both misspellings and inappropriate capitalization
Number of subjects: 301

Group type: COMPARATOR
Intervention: Control excerpts
Number of subjects: 301
Study: 35118644

Group type: EXPERIMENTAL
Intervention: Dextran-based prime
Number of subjects: 61

Group type: COMPARATOR
Intervention: Crystalloid prime
Number of subjects: 61
Study: 34364737

Group type: EXPERIMENTAL
Intervention: Mulabandha yoga therapy (MYT) for 12 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: No MYT (control group)
Number of subjects: 50
Study: 33203367

Group type: EXPERIMENTAL
Intervention: Induction of labor
Number of subjects: 1347

Group type: COMPARATOR
Intervention: Pre-labor cesarean section
Number of subjects: 1347
Study: 35887850

Group type: EXPERIMENTAL
Intervention: PROMUFRA multicomponent frailty program for 20 weeks
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: PROMUFRA multicomponent frailty program
Number of subjects: 81

Group type: COMPARATOR
Intervention: Control group (CG) continued routine activities
Number of subjects: 81
Study: 35589771

Group type: EXPERIMENTAL
Intervention: Cognitive dual task training (CDTT, n=9)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Motor dual task training (MDTT, n=11)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional physical therapy (CPT, n=10)
Number of subjects: 30
Study: 33596675

Group type: EXPERIMENTAL
Intervention: Endovascular therapy plus standard medical therapy
Number of subjects: 182

Group type: COMPARATOR
Intervention: Standard medical therapy alone
Number of subjects: 182
Study: 36066991

Group type: EXPERIMENTAL
Intervention: Eritoran (12 mg I.V. every 12 h)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Intralipid (30 ml/h) + vehicle
Number of subjects: 19

Group type: COMPARATOR
Intervention: Saline (30 ml/h) + vehicle
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Intralipid (30 ml/h) + eritoran (12 mg I.V. every 12 h)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 19
Study: 33084075

Group type: EXPERIMENTAL
Intervention: Dyract XP
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Equia Forte
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: ChemFil Rock
Number of subjects: 57
Study: 35245626

Group type: EXPERIMENTAL
Intervention: AI-supported detection (dentalXrai Pro 1.0.4)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Detection without AI
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: AI-supported detection
Number of subjects: 23
Study: 33216969

Group type: EXPERIMENTAL
Intervention: Silicone foam dressings with standard prevention (n = 1087 pooled from experimental groups 1 and 2)
Number of subjects: 1633

Group type: COMPARATOR
Intervention: Standard of care (n = 546)
Number of subjects: 1633

Group type: EXPERIMENTAL
Intervention: Silicone foam dressings with standard prevention (n = 1087)
Number of subjects: 1633
Study: 32920689

Group type: EXPERIMENTAL
Intervention: Group 1 (patients with AAA)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Group 2 (patients without AAA)
Number of subjects: 220
Study: 36241121

Group type: EXPERIMENTAL
Intervention: 300 μM Mn
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: 900 μM Mn
Number of subjects: 4

Group type: COMPARATOR
Intervention: Control (2 μM Mn)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: L. multiflorum (exotic species)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: P. notatum (native species)
Number of subjects: 4
Study: 32495305

Group type: EXPERIMENTAL
Intervention: Reproductive healthcare services from obstetrics and gynecology
Number of subjects: 1500

Group type: EXPERIMENTAL
Intervention: Reproductive healthcare at health department
Number of subjects: 1500

Group type: EXPERIMENTAL
Intervention: Most effective methods of contraception
Number of subjects: 1500

Group type: EXPERIMENTAL
Intervention: General contraceptive use and insurance coverage
Number of subjects: 1500
Study: 32311780

Group type: EXPERIMENTAL
Intervention: Lipegfilgrastim (LIPEG) 6 mg
Number of subjects: 77

Group type: COMPARATOR
Intervention: Pegfilgrastim (PEG) 6 mg
Number of subjects: 77
Study: 35903379

Group type: EXPERIMENTAL
Intervention: Nomogram for cancer-specific survival (CSS) prediction based on multivariate Cox regression model.
Number of subjects: 44975

Group type: EXPERIMENTAL
Intervention: Nomogram for cancer-specific survival (CSS) prediction.
Number of subjects: 44975
Study: 33345452

Group type: EXPERIMENTAL
Intervention: SGLT2 inhibitors (assumed risk reduction based on EMPA-REG OUTCOME and DECLARE-TIMI 58 trials)
Number of subjects: 23340

Group type: EXPERIMENTAL
Intervention: SGLT2 inhibitors (75% adoption)
Number of subjects: 23340
Study: 32559278

Group type: EXPERIMENTAL
Intervention: Nutrition education lessons through SNAP‐Ed
Number of subjects: 0
Study: 36057390

Group type: EXPERIMENTAL
Intervention: Four-staged invitation procedure (pre-notification, invitation, and two reminders)
Number of subjects: 59041

Group type: EXPERIMENTAL
Intervention: Three-staged invitation procedure (invitation and two reminders)
Number of subjects: 59041

Group type: EXPERIMENTAL
Intervention: Three-staged invitation procedure (pre-notification, invitation, and one reminder)
Number of subjects: 59041

Group type: COMPARATOR
Intervention: Control group (usual procedure: invitation and one reminder)
Number of subjects: 59041

Group type: EXPERIMENTAL
Intervention: Extra reminder for males
Number of subjects: 59041

Group type: EXPERIMENTAL
Intervention: Extra reminder for females
Number of subjects: 59041

Group type: EXPERIMENTAL
Intervention: Four-staged invitation procedure for age group 50-59 years
Number of subjects: 59041
Study: 33620016

Group type: EXPERIMENTAL
Intervention: rSIFN-co nebulization
Number of subjects: 94

Group type: COMPARATOR
Intervention: Interferon-alpha nebulization
Number of subjects: 94
Study: 32534376

Group type: EXPERIMENTAL
Intervention: Zinc supplementation (30 mg elemental zinc)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 34978169

Group type: EXPERIMENTAL
Intervention: First semen sample after 2-7 days of abstinence
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Second semen sample collected 1-3 hours after the first
Number of subjects: 67
Study: 34095908

Group type: EXPERIMENTAL
Intervention: Real-time monitoring of DNA hybridization on spherical particles functionalized with oligonucleotide capture probes in a microfluidic system.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bead bed hybridization with Streptococcus agalactiae cfb gene amplicons.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional (passive) microfluidic microarray hybridization on glass slides.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Centrifugally-driven (active) microfluidic microarray hybridization on glass slides.
Number of subjects: 0
Study: 35112890

Group type: EXPERIMENTAL
Intervention: ivabradine (5 mg BID, 1-week)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 32734564

Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression (IPC) combined with rehabilitation training
Number of subjects: 74

Group type: COMPARATOR
Intervention: Conventional drug therapy and rehabilitation training (Control)
Number of subjects: 74
Study: 33269798

Group type: EXPERIMENTAL
Intervention: Sinovac EV71 vaccine
Number of subjects: 600

Group type: COMPARATOR
Intervention: Control EV71 vaccine
Number of subjects: 600
Study: 33271095

Group type: EXPERIMENTAL
Intervention: Gemogenovatucel-T (1 × 10^7 cells per injection), administered intradermally (one per month) for a minimum of four and up to 12 doses.
Number of subjects: 91

Group type: COMPARATOR
Intervention: Placebo, administered intradermally (one per month) for a minimum of four and up to 12 doses.
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Gemogenovatucel-T
Number of subjects: 91

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 91
Study: 33713335

Group type: EXPERIMENTAL
Intervention: Self-esteem group with treatment as usual (TAU)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Treatment as usual (TAU) alone
Number of subjects: 50
Study: 33094848

Group type: EXPERIMENTAL
Intervention: Nutrition support interventions during acute COVID-19
Number of subjects: 439

Group type: EXPERIMENTAL
Intervention: Registered dietitian nutritionist counseling
Number of subjects: 439

Group type: EXPERIMENTAL
Intervention: Nutrition topics related to food insecurity and societal infrastructure
Number of subjects: 439

Group type: EXPERIMENTAL
Intervention: Malnutrition management
Number of subjects: 439

Group type: EXPERIMENTAL
Intervention: Research on transcultural factors
Number of subjects: 439

Group type: EXPERIMENTAL
Intervention: Nutrition research gaps in pediatrics
Number of subjects: 439

Group type: EXPERIMENTAL
Intervention: Nutrition research gaps in micronutrients and bariatric surgery
Number of subjects: 439

Group type: EXPERIMENTAL
Intervention: Home enteral and parenteral nutrition support
Number of subjects: 439
Study: 35939559

Group type: COMPARATOR
Intervention: ESO 20 mg plus AMX 750 mg, Qid for 14 days (Group A)
Number of subjects: 945

Group type: EXPERIMENTAL
Intervention: ESO 40 mg Bid plus AMX 1 g Tid for 14 days (Group B)
Number of subjects: 945

Group type: EXPERIMENTAL
Intervention: ESO 20 mg plus AMX 1 g, Tid for 14 days (Group C)
Number of subjects: 945
Study: 34092255

Group type: EXPERIMENTAL
Intervention: Topical high-linoleate sunflower seed oil (SSO) applied at 3 g/kg three times daily for 10 days
Number of subjects: 212

Group type: COMPARATOR
Intervention: No emollient (control group)
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Topical high-linoleate sunflower seed oil (SSO)
Number of subjects: 212
Study: 32838554

Group type: EXPERIMENTAL
Intervention: Bleeding (BARC 2, 3, or 5)
Number of subjects: 15968

Group type: EXPERIMENTAL
Intervention: Myocardial Infarction (MI)
Number of subjects: 15968

Group type: EXPERIMENTAL
Intervention: Repetitive bleeding
Number of subjects: 15968

Group type: EXPERIMENTAL
Intervention: Repetitive MI
Number of subjects: 15968

Group type: EXPERIMENTAL
Intervention: Both bleeding and MI
Number of subjects: 15968

Group type: EXPERIMENTAL
Intervention: De-escalation of antiplatelet therapy at the time of BARC 3 bleeding
Number of subjects: 15968

Group type: COMPARATOR
Intervention: Overall mortality
Number of subjects: 15968
Study: 33608479

Group type: EXPERIMENTAL
Intervention: HIV-positive MSM
Number of subjects: 355

Group type: COMPARATOR
Intervention: HIV-negative MSM
Number of subjects: 355
Study: 34663681

Group type: EXPERIMENTAL
Intervention: 3-minute high-intensity interval exercise program (jumps, squats, various steps) implemented twice weekly over 10 weeks for 10 to 25 minutes per session
Number of subjects: 2101

Group type: COMPARATOR
Intervention: Usual physical education class
Number of subjects: 2101
Study: 33351532

Group type: EXPERIMENTAL
Intervention: HIV seroconversion
Number of subjects: 605

Group type: EXPERIMENTAL
Intervention: GC/CT positive cases
Number of subjects: 605

Group type: COMPARATOR
Intervention: GC/CT negative controls
Number of subjects: 605
Study: 32433428

Group type: EXPERIMENTAL
Intervention: Oral carbohydrate (CHO) group
Number of subjects: 82

Group type: COMPARATOR
Intervention: IV Dextrose group
Number of subjects: 82
Study: 34036337

Group type: EXPERIMENTAL
Intervention: Passive mobilization (30 minutes, 5 times/week for 4 weeks)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Routine treatment (Control group)
Number of subjects: 45
Study: 33300809

Group type: EXPERIMENTAL
Intervention: High power (45 W)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard CLOSE protocol (35 W)
Number of subjects: 100
Study: 32602792

Group type: EXPERIMENTAL
Intervention: Singing in the last three days
Number of subjects: 960

Group type: EXPERIMENTAL
Intervention: Playing in the last three days
Number of subjects: 960

Group type: EXPERIMENTAL
Intervention: Engagement in reading, counting, drawing, 'showing and naming', and 'chatting'
Number of subjects: 960
Study: 34482350

Group type: EXPERIMENTAL
Intervention: F/TAF 200 mg/25 mg
Number of subjects: 79

Group type: COMPARATOR
Intervention: F/TDF 200 mg/300 mg
Number of subjects: 79
Study: 32089078

Group type: EXPERIMENTAL
Intervention: 12-session weekly yoga intervention
Number of subjects: 37

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Yoga intervention
Number of subjects: 37

Group type: COMPARATOR
Intervention: TAU
Number of subjects: 37
Study: 35319653

Group type: EXPERIMENTAL
Intervention: Viscotrabeculotomy with anterior chamber irrigation
Number of subjects: 43

Group type: COMPARATOR
Intervention: Ahmed glaucoma valve implantation
Number of subjects: 43
Study: 33337732

Group type: EXPERIMENTAL
Intervention: Intradermal injections of 50 units of BoNTA
Number of subjects: 30

Group type: COMPARATOR
Intervention: Laser-assisted transcutaneous BoNTA delivery using fractional CO2 laser (25, 50, and 75 units)
Number of subjects: 30
Study: 33287836

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) treatment in PCOS patients (PCOS-GH)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Control group (PCOS-C)
Number of subjects: 93
Study: 32618554

Group type: EXPERIMENTAL
Intervention: Laboratory analysis of Na content in bread
Number of subjects: 3239

Group type: COMPARATOR
Intervention: Nutrient labels of bread
Number of subjects: 3239

Group type: EXPERIMENTAL
Intervention: Comparison of salt content per roll
Number of subjects: 3239

Group type: EXPERIMENTAL
Intervention: Consumption of rolls
Number of subjects: 3239
Study: 33075788

Group type: EXPERIMENTAL
Intervention: Low FODMAP diet
Number of subjects: 27

Group type: COMPARATOR
Intervention: Diet based on NICE guidelines
Number of subjects: 27
Study: 36263739

Group type: EXPERIMENTAL
Intervention: Osmotic-release oral system methylphenidate (OROS-methylphenidate)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34407810

Group type: EXPERIMENTAL
Intervention: 6-step LSPPDM pedagogy (Learn, See, Practice, Prove, Do, Maintain)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Traditional 2-step method (Learn, Practice)
Number of subjects: 60
Study: 35948418

Group type: EXPERIMENTAL
Intervention: OPEP therapy using Acapella device for 3 months
Number of subjects: 122

Group type: COMPARATOR
Intervention: Usual care (including active cycle of breathing technique)
Number of subjects: 122
Study: 34391315

Group type: EXPERIMENTAL
Intervention: Pilates training
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Suspension training
Number of subjects: 30
Study: 35623878

Group type: EXPERIMENTAL
Intervention: Intravenous 2 g of vitamin C in normal saline
Number of subjects: 80

Group type: COMPARATOR
Intervention: Normal saline therapy (control)
Number of subjects: 80
Study: 34503460

Group type: EXPERIMENTAL
Intervention: Skull remodeling surgery, Tumor Treating Fields therapy (TTFields), and best practice oncology
Number of subjects: 84

Group type: COMPARATOR
Intervention: Tumor Treating Fields therapy (TTFields) and best physicians choice oncological treatment (control arm)
Number of subjects: 84
Study: 32618829

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate (MgSO4) 300 mg daily for 6 months
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 34259302

Group type: COMPARATOR
Intervention: 30% RD43 rice noodles
Number of subjects: 0

Group type: COMPARATOR
Intervention: 10-40% RD43 rice flour
Number of subjects: 0
Study: 33111883

Group type: EXPERIMENTAL
Intervention: Conventional restorative Glass Ionomer Cement (Fuji Bulk)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Posterior resin composite (G-ænial Posterior)
Number of subjects: 30
Study: 35871083

Group type: EXPERIMENTAL
Intervention: High-dose Neu2000K
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Low-dose Neu2000K
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study: 33483990

Group type: EXPERIMENTAL
Intervention: Exercise Training (ET)
Number of subjects: 39

Group type: COMPARATOR
Intervention: CPAP
Number of subjects: 39
Study: 32682962

Group type: EXPERIMENTAL
Intervention: Transcatheter tricuspid valve intervention (TTVI)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Guideline directed medical therapy (GDMT)
Number of subjects: 124
Study: 36210809

Group type: EXPERIMENTAL
Intervention: Mesalazine (4.0 g/d, once a day for 3 months)
Number of subjects: 82
Study: 32589129

Group type: EXPERIMENTAL
Intervention: Loading Dose (LD) 600 mg
Number of subjects: 402

Group type: COMPARATOR
Intervention: Reloading (RL) 300 mg
Number of subjects: 402

Group type: COMPARATOR
Intervention: Maintenance Dose (MD) 75 mg/day
Number of subjects: 402
Study: 36093863

Group type: EXPERIMENTAL
Intervention: tDCS + cognitive training
Number of subjects: 62

Group type: COMPARATOR
Intervention: tDCS alone
Number of subjects: 62

Group type: COMPARATOR
Intervention: Cognitive training alone
Number of subjects: 62
Study: 33945920

Group type: EXPERIMENTAL
Intervention: Pharmaceutical care (PC) group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (UC) group
Number of subjects: 0
Study: 32412119

Group type: EXPERIMENTAL
Intervention: Cryoballoon ablation (CBA) for pulmonary vein isolation (PVI) and left atrial substrate modification
Number of subjects: 26
Study: 34481420

Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (PBM) combined with standard skincare (2x/week) during the complete radiotherapy course
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo treatment combined with standard skincare (2x/week)
Number of subjects: 71
Study: 34815179

Group type: EXPERIMENTAL
Intervention: Serum metabolic profiling on day 1
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Serum metabolic profiling on day 8
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Serum levels of 1-arachidonoyl-lysoPC and 1-eicosatetraenoyl-lysoPC
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Serum levels of amino acids and amino acid metabolites
Number of subjects: 202
Study: 34578999

Group type: EXPERIMENTAL
Intervention: Macronutrient-based diet
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Time-restricted feeding (16:8)
Number of subjects: 42